Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Randomised Trial Comparing Efficacy of Continuous Subcutaneous Insulin Infusion(CSII) and Multiple Daily Insulin Injections (MDII) in Improving Glycemic Control and Quality of Life in Poorly Regulated Type 1 Diabetic Children.

NCT00462371 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT00462371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Randomised Trial Comparing Efficacy of Continuous Subcutaneous Insulin Infusion(CSII) and Multiple Daily Insulin Injections (MDII) in Improving Glycemic Control and Quality of Life in Poorly Regulated Type 1 Diabetic Children.
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2002
Completion date
February 29, 2004
Enrollment
38
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child, diabetes mellitus, type 1